Facebook
Twitter
LinkedIn
Forward
Mass General Cancer Center Practice-Changing Updates in Hematologic Malignancies
Please note, access to symposium recordings is included with registration.
Access will be available for 30 days post event.
With several new drug and cellular therapies as well as an expansion of our understanding of the biologic heterogeneity of hematologic malignancies, there is a need for ongoing education in the area of hematologic malignancies. This interactive webinar series will focus on current best practices and major updates in the biology, diagnosis, and management of hematologic malignancies.
Each 90-minute webinar will have two talks followed by 30 minutes of discussion and audience questions. Presenters will include internationally-known disease experts from Mass General Cancer Center covering practice-changing updates in cellular therapies, transplant, myeloma, leukemia, and lymphoma
Target Audience
This activity is intended for physicians, nurses, physician assistants, other members of healthcare team (regional) with specialties such as general practice, hematology, hematology/oncology, medical oncology, primary care, and radiation oncology.
Learning Objectives
Upon completion of this activity, participants will be able to:
- Identify new therapies available for hematologic malignancies.
- Discuss practice-changing updates in the management of hematologic malignancies.
- Discuss new concepts in palliative care and survivorship.
- Determine appropriate timing to consider transplantevaluation and cellular therapy referral for hematologic malignancies.
Additional Information
Massachusetts General Hospital Cancer Center & Mass General Brigham
February 28, 2023 - Transplants
Speakers: Zach DeFilipp, MD & Areej El-Jawahri, MD
March 14, 2023 - Leukemia
Speakers: Andrew Brunner, MD & Gaby Hobbs, MD
March 22, 2023 - Cellular Therapies
Speakers: Jeremy Abramson, MD & Matt Frigault, MD
April 12, 2023 - Myeloma
Speakers: Diana Cirstea, MD & Noopur Raje, MD
May 3, 2023 - Lymphoma
Speakers: P. Connor Johnson, MD & Jake Soumerai, MD
Course Director:
P. Connor Johnson, MD
Hematology/Oncology, Massachusetts General Hospital Cancer Center
Instructor in Medicine, Harvard Medical School
Faculty:
Jeremy Abramson, MD
Director, Jon and Jo Ann Hagler Center for Lymphoma, Massachusetts General Hospital Cancer Center
Associate Professor of Medicine, Harvard Medical School
Andrew Brunner, MD
Assistant Professor of Medicine, Harvard Medical School
Massachusetts General Hospital Cancer Center
Diana Cirstea, MD
Attending Physician
Multiple Myeloma Treatment Program
Massachusetts General Hospital Cancer Center
Zach DeFilipp, MD
Director, BMT Clinical Research, Massachusetts General Hospital Cancer Center
Assistant Professor of Medicine, Harvard Medical School
Areej El-Jawahri, MD
Associate Director, Cancer Outcomes Research and Education Program
Director, Bone Marrow Transplant Survivorship Program, Massachusetts General Hospital Cancer Center
Associate Professor of Medicine, Harvard Medical School
Matt Frigault, MD
Administrative Director, Cellular Therapy Service, Massachusetts General Hospital Cancer Center
Assistant Professor of Medicine, Harvard Medical School
Gaby Hobbs, MD
Clinical Director, Leukemia Service, Massachusetts General Hospital Cancer Center
Assistant in Medicine, Harvard Medical School
Noopur Raje, MD
Director, Center for Multiple Myeloma
Massachusetts General Hospital Cancer Center
Jake Soumerai, MD
Clinical Investigator in Lymphoma, Medicine, Massachusetts General Hospital
Assistant Professor, Medicine, Harvard Medical School
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
AMA PRA Category 1 CreditsTM
Mass General Brigham designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing
Mass General Brigham designates this activity for 1.5 ANCC contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.
Physician Assistants
Mass General Brigham has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.50 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.